René Russo
2021 - Xilio Therapeutics
In 2021, René Russo earned a total compensation of $5.5M as President and Chief Executive Officer at Xilio Therapeutics, a 118% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $379,500 |
|---|---|
| Option Awards | $4,590,907 |
| Salary | $485,014 |
| Other | $9,284 |
| Total | $5,464,705 |
Russo received $4.6M in option awards, accounting for 84% of the total pay in 2021.
Russo also received $379.5K in non-equity incentive plan, $485K in salary and $9.3K in other compensation.
Rankings
In 2021, René Russo's compensation ranked 2,345th out of 12,415 executives tracked by ExecPay. In other words, Russo earned more than 81.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,345 out of 12,415 | 81st |
Division Manufacturing | 920 out of 5,505 | 83rd |
Major group Chemicals And Allied Products | 350 out of 2,375 | 85th |
Industry group Drugs | 304 out of 2,096 | 86th |
Industry Pharmaceutical Preparations | 196 out of 1,546 | 87th |
Source: SEC filing on April 26, 2022.
Russo's colleagues
We found two more compensation records of executives who worked with René Russo at Xilio Therapeutics in 2021.